April 6, 2015
Misfit Flash, one of the devices that will be used in the study.
AARP has launched a new research initiative, called Project Catalyst, where the organization will work with partners including Pfizer, UnitedHealthcare, and Georgia Tech to promote an increased focus on users over 50 in digital health research and development. The first project of the new initiative, focused on sleep and activity...
March 27, 2015
For the more than six years that MobiHealthNews has been covering the world of mobile and digital health pharma has always been one group that seemed just ready to break in. While providers and even payors have publicly gotten their hands dirty experimenting with telemedicine, remote patient monitoring, and patient engagement apps, pharma has largely been moving in the shadows through investments...
March 25, 2015
Vital Art and Science, developers of myVisionTrack, a vision test service for patients with age-related macular degeneration or diabetic eye disease, has received a second FDA clearance for their platform, which includes an app and a provider dashboard. They will also soon launch a major clinical trial in partnership with the Scripps Translational Science Institute and Roche, according to the...
March 20, 2015
Cincinnati, Ohio-based MedaCheck, a company that sells a dedicated medication reminder tablet for seniors, has raised $1.1 million in a round led by Queen City Angels.
The tablet aims to help seniors who have trouble managing their medication. When the MedaCheck tablet is purchased, the senior or their caregiver will send MedaCheck a list of all of the user's medications and supplements. From...
March 18, 2015
Pharma-focused mobile clinical trial data collection company Clinical Ink has merged with CentrosHealth, formerly MyHealthBook, which makes configurable mobile apps for clinical trial patient engagement. As part of the deal, MPM Capital, which founded CentrosHealth, will make an additional investment in Clinical Ink, as will F2 Ventures, FCA Venture Partners and other existing Clinical Ink...
March 16, 2015
More collaboration between chief information officers (CIO) and chief marketing officers (CMO) at pharmaceutical companies could lead to more optimized use of digital technology, according to a survey from Accenture.
Accenture interviewed 22 CIOs and 24 CMOs from pharmaceutical companies in eight countries that were bringing in at least $5 billion in annual revenues.
While 91 percent of CIOs at...
March 2, 2015
Going "beyond the pill" doesn't just mean devising new digital technologies to market a drug or promote medication adherence with software tools. Sometimes it means engaging patients in their patient journey long before a drug enters into the equation -- and hoping it pays dividends later on.
Jeremy Shepler, senior director of diabetes marketing at Novo Nordisk, spoke at the ePharma Summit last...
February 27, 2015
The ePharma Summit in New York City this week was a veritable smorgasbord of new mobile health data. Monique Levy shared some new data (and insights) from Manhattan Research, Tom Jones from Makovsky Health shared data about consumer mobile health use, and, finally, ComScore's John Mangano shared data from a survey of 2,929 individuals, broken down by generation.
"So what I did was I had my team...
February 27, 2015
By Bradley Merrill Thompson
Over the last couple years, FDA has clarified the scope of its regulation over mobile health. In the agency’s September 2013 guidance, FDA spelled out its oversight for some of the most common mobile medical apps. Then, last month, in two separate draft guidances FDA explained the limits on its oversight of apps used for general wellness like fitness trackers, as well...
February 25, 2015
San Francisco-based Iodine, the startup from former Wired executive editor Thomas Goetz and former Google engineer Matt Mohebbi that launched last fall, is already starting to see some interesting data come out of its crowdsourced medication reviews.
For instance, Goetz said at the ePharma Summit in New York City, Iodine collects ratings on drugs in three categories, one of which is an overall...